Quantcast
Last updated on April 24, 2014 at 14:17 EDT
Climbing Mount Everest To Learn More About Type 2 Diabetes

Climbing Mount Everest To Learn More About Type 2 Diabetes

April Flowers for redOrbit.com - Your Universe Online Most people engage in extreme sports, such as climbing Mount Everest, in an attempt to gain insight about themselves. A group of researchers from the University of Southampton and University...

Latest Eli Lilly and Company Stories

2014-04-24 08:32:41

-- First-quarter 2014 revenue declined 16 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by strong volume growth outside the United States, particularly in Japan and the emerging markets. INDIANAPOLIS, April 24, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2014. $ in millions, except per share data First Quarter %...

2014-04-23 23:17:50

Flood Law Group announced today that they have updated the Actos Lawsuit information page on their website after a jury recently awarded a settlement of $9 billion in punitive damages to plaintiffs in the suit against Takeda Pharmaceutical Co. and Eli Lilly & Co. The nearly 2,700 suits have been consolidated before U.S. District Judge Rebecca Doherty at the U.S. District Court for the Western District of Louisiana under MDL No. 2299. Washington, D.C. (PRWEB) April 22, 2014 Flood Law...

2014-04-22 00:21:28

- $5.4 billion deal creates world's second-largest animal health company. INDIANAPOLIS, April 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that will strengthen and diversify Lilly's own animal health business, Elanco. Upon completion of the acquisition, Elanco will be the second-largest animal health company in terms of global revenue, will...

2014-04-21 20:21:44

INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA(TM) (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, CYRAMZA becomes the first FDA-approved treatment for patients...

2014-04-20 23:01:49

Huge amount of damages awarded to New York man who was diagnosed with bladder cancer that jurors were told was caused by diabetes drug Actos. National network of attorneys continues offer of no-cost consultations to consumers seeking compensation over similar claims. San Diego, CA (PRWEB) April 20, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced that it is providing consumers who may have been affected by Actos...

2014-04-20 23:01:14

A federal jury’s decision to award billions of dollars in damages to a bladder cancer patient who took Actos could mean that others in the same situation may also have a right to seek compensation. Raleigh, NC (PRWEB) April 20, 2014 Last week, the Osaka, Japan-based company that produces the diabetes drug Actos and their American marketing partner Eli Lilly were ordered to pay more than $9 billion because Takeda allegedly concealed cancer risks associated with its Actos diabetes drug....

2014-04-19 23:00:54

Japanese research suggests a biomarker called osteopontin could help some mesothelioma patients avoid the trial-and-error approach to treatment. Raleigh, NC (PRWEB) April 19, 2014 Scientists say testing for the structural glycoprotein osteopontin in mesothelioma tissue samples could help streamline the process of selecting an effective treatment. Details on the new study have just been posted on the Cancer Monthly website and can be read by clicking here. Doctors in the Department of...

2014-04-17 23:08:10

In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights if they are diagnosed. Raleigh, NC (PRWEB) April 17, 2014 Cancer information site Cancer Monthly is advising Actos users to be aware of the symptoms of bladder cancer after a jury in the U.S. District Court for Western Louisiana concluded...

2014-04-17 23:01:49

The Firm is currently offering free and confidential Actos lawsuit evaluations to individuals who allegedly developed bladder cancer after taking the diabetes drug for 12 months or longer. New York, NY (PRWEB) April 17, 2014 Bernstein Liebhard LLP notes recent developments in an Actos lawsuit (http://www.theactoslawsuitcenter.com/) trial currently underway in Nevada state court, which comes at the heels of a significant victory in Louisiana for a plaintiff whose federally-filed case...

2014-04-16 23:10:18

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWEB) April 16, 2014 The diabetes drug Actos has made news headlines this week after a jury decided that its manufacturer, Takeda, was responsible for causing bladder cancer in this case. But Actos is just one of several pioglitazone-containing drugs produced by Takeda and all of them...


Latest Eli Lilly and Company Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (2 articles) »